Mackenzie Financial Corp raised its stake in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 22.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 296,461 shares of the biopharmaceutical company’s stock after purchasing an additional 53,641 shares during […]
Cognios Beta Neutral Large Cap Fund LP lessened its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 7.6% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,315 shares of the biopharmaceutical company’s stock after selling 687 shares during the […]
Cognios Beta Neutral Large Cap Fund LP trimmed its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 7.6% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 8,315 shares of the biopharmaceutical company’s stock after selling 687 shares during the quarter. Cognios Beta Neutral Large Cap Fund LP’s holdings in Incyte were […]
Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its position in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 25.3% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 101,064 shares of the biopharmaceutical company’s stock after buying an additional 20,400 shares […]
Victory Capital Management Inc. decreased its holdings in Incyte Co. (NASDAQ:INCY – Free Report) by 9.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 136,062 shares of the biopharmaceutical company’s stock after selling 13,771 shares during the period. […]